Sheth KR, Clary BM, Ychou M, Delpero JR, Rougier P. Management of hepatic metastases from colorectal cancer.
Clin Colon Rectal Surg 2005;
18:215-23. [PMID:
20011304 PMCID:
PMC2780092 DOI:
10.1055/s-2005-916282]
[Citation(s) in RCA: 63] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
The majority of hepatic metastases in the United States occur in patients with a primary colorectal malignancy. Advances in technology combined with increasing surgeon experience have broadened the treatment options available for hepatic metastases from colorectal cancer. Surgical resection is the most effective therapy for metastatic colorectal cancer isolated to the liver. The aim of this article is to discuss the role of locally aggressive treatment options including resection, ablation, and regional chemotherapy in the management of patients with metastases from colorectal cancer.
Collapse